Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Spotlight: management of primary biliary cholangitis

Primary biliary cholangitis (PBC) is a rare, auto-immune cholestatic liver disease. This article discusses the management of PBC and emerging potential treatment options.

Liver disease is becoming more prevalent in the UK, and it is the only major chronic disease where death rates are rising.1

Over the past few decades, new medications, technologies, and other innovations have been developed to try and tackle this growing need, but innovations in rare liver disease are still lacking.

For example, there have been no new effective treatments for primary biliary cholangitis (PBC) – a rare, auto-immune cholestatic liver disease – for more than a decade.


This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
New User Registration
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy
Verified by MonsterInsights